Your browser doesn't support javascript.
loading
GPR55: A therapeutic target for Parkinson's disease?
Celorrio, Marta; Rojo-Bustamante, Estefanía; Fernández-Suárez, Diana; Sáez, Elena; Estella-Hermoso de Mendoza, Ander; Müller, Christa E; Ramírez, María J; Oyarzábal, Julen; Franco, Rafael; Aymerich, María S.
Affiliation
  • Celorrio M; Program of Neurosciences, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona 31008, Spain; Department of Biochemistry and Genetics, School of Science, University of Navarra, Pamplona 31008, Spain.
  • Rojo-Bustamante E; Program of Neurosciences, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona 31008, Spain; Department of Biochemistry and Genetics, School of Science, University of Navarra, Pamplona 31008, Spain.
  • Fernández-Suárez D; Program of Neurosciences, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona 31008, Spain.
  • Sáez E; Small Molecule Discovery Platform, Molecular Therapeutics Program, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona 31008, Spain.
  • Estella-Hermoso de Mendoza A; Small Molecule Discovery Platform, Molecular Therapeutics Program, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona 31008, Spain.
  • Müller CE; PharmaCenter Bonn, Pharmaceutical Institute, Pharmaceutical Chemistry I, An der Immenburg 4, D-53121 Bonn, Germany.
  • Ramírez MJ; Department of Pharmacology, School of Pharmacy, University of Navarra, Pamplona 31008, Spain; IdiSNA, Navarra Institute for Health Research, Pamplona 31008, Spain.
  • Oyarzábal J; Small Molecule Discovery Platform, Molecular Therapeutics Program, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona 31008, Spain.
  • Franco R; Program of Neurosciences, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona 31008, Spain; Department of Biochemistry and Molecular Biology, University of Barcelona, Barcelona 08028, Spain.
  • Aymerich MS; Program of Neurosciences, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona 31008, Spain; Department of Biochemistry and Genetics, School of Science, University of Navarra, Pamplona 31008, Spain; IdiSNA, Navarra Institute for Health Research, Pamplona 31008, Spain. Electron
Neuropharmacology ; 125: 319-332, 2017 Oct.
Article in En | MEDLINE | ID: mdl-28807673
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinsonian Disorders / Receptors, Cannabinoid / Cannabinoid Receptor Agonists / Antiparkinson Agents Limits: Animals Language: En Journal: Neuropharmacology Year: 2017 Type: Article Affiliation country: Spain
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinsonian Disorders / Receptors, Cannabinoid / Cannabinoid Receptor Agonists / Antiparkinson Agents Limits: Animals Language: En Journal: Neuropharmacology Year: 2017 Type: Article Affiliation country: Spain